Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA12 | O43570 | 14/20 | 0.47 |
| ▸ | CA1 | P00915 | 14/20 | 0.47 |
| ▸ | CA2 | P00918 | 14/20 | 0.47 |
| ▸ | CA9 | Q16790 | 14/20 | 0.47 |
| ▸ | SENP1 | Q9P0U3 | 1/20 | 0.39 |
| ▸ | OPRM1 | P35372 | 1/20 | 0.37 |
| ▸ | ADORA2A | P29274 | 1/20 | 0.35 |
| ▸ | ADORA1 | P30542 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL23723230 | 0.99 | CA12 (0.47) | CA12CA1CA2CA9SENP1 | |
| SCHEMBL23745926 | 0.90 | CA12 (0.48) | CA12CA1CA2CA9SENP1 | |
| SCHEMBL23745934 | 0.90 | CA12 (0.47) | CA12CA1CA2CA9SENP1 | |
| Hydrochloric Acid SCHEMBL23723361 | 0.89 | CA12 (0.46) | CA12CA1CA2CA9SENP1 | |
| Hydrochloric Acid SCHEMBL23723394 | 0.83 | CA12 (0.43) | CA12CA1CA2CA9SENP1 | |
| SCHEMBL23723342 | 0.77 | CA12 (0.44) | CA12CA1CA2CA9SENP1 | |
| SCHEMBL30633635 | 0.74 | CA12 (0.42) | CA12CA1CA2CA9SENP1 | |
| Hydrochloric Acid SCHEMBL23723283 | 0.72 | CA12 (0.56) | CA12CA1CA2CA9SENP1 | |
| SCHEMBL23745961 | 0.71 | CA12 (0.52) | CA12CA1CA2CA9 | |
| Hydrochloric Acid SCHEMBL23723289 | 0.71 | CA12 (0.51) | CA12CA1CA2CA9 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2021155439-A1 | BIOPROBES FOR LYSYL OXIDASES AND USES THEREOF | PHARMAXIS LTD. (AU) | 2021-08-12 | — | — | WO | disclosed |